Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;23(6):1179-1184.
doi: 10.1007/s12094-020-02508-2. Epub 2021 Jan 1.

Genetic predisposition to fetal and neonatal cancer

Affiliations

Genetic predisposition to fetal and neonatal cancer

A Escudero et al. Clin Transl Oncol. 2021 Jun.

Abstract

Background: Neonatal tumors represent an extremely rare and heterogeneous disease with an unknown etiology. Due to its early onset, it has been proposed that genetic factors could play a critical role; however, germline genetic analysis is not usually performed in neonatal cancer patients PATIENTS AND METHODS: To improve the identification of cancer genetic predisposition syndromes, we retrospectively review clinical characteristics in 45 patients with confirmed tumor diagnosis before 28 days of age, and we carried out germline genetic analysis in 20 patients using next-generation sequencing and directed sequencing.

Results: The genetic studies did not find any germline mutation except patients diagnosed with bilateral retinoblastoma who harbored RB1 germline mutations.

Conclusions: Our results suggest that genetic factors have almost no higher impact in most neonatal tumors. However, since the heterogeneity of the tumors and the small sample size analyzed, we recommend complementary and centralized germline studies to discard the early onset as an additional criterion to take into account to improve the identification of cancer genetic predisposition syndromes in neonates.

Keywords: Congenital cancer; Fetal and neonatal cancer; Genetic predisposition; Germline mutations; Rare tumors; Retinoblastoma.

PubMed Disclaimer

References

    1. Isaacs H Jr. Congenital and neonatal malignant tumors. A 28-year experience at Children’s Hospital of Los Angeles. Am J Pediatr Hematol/oncol. 1987;9(2):121–9. - DOI
    1. Moore SW. Neonatal tumours. Pediatr Surg Int. 2013;29(12):1217–29. https://doi.org/10.1007/s00383-013-3424-3 . - DOI - PubMed
    1. Moore SW, Satge D, Sasco AJ, Zimmermann A, Plaschkes J. The epidemiology of neonatal tumours. Report of an international working group. Pediatr Surg Int. 2003;19(7):509–19. https://doi.org/10.1007/s00383-003-1048-8 . - DOI - PubMed
    1. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. Infant cancer in the US: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol. 1997;19(5):428–32. - DOI
    1. Parkes SE, Muir KR, Southern L, Cameron AH, Darbyshire PJ, Stevens MC. Neonatal tumours: a thirty-year population-based study. Med Pediatr Oncol. 1994;22(5):309–17. - DOI

LinkOut - more resources